Neuroscientific Biopharmaceuticals Ltd (NSB) — Cash Flow Quality Index
Neuroscientific Biopharmaceuticals Ltd (NSB) has a Cash Flow Quality Index of 1.04x as of June 2024. Operating cash flow of AU$1.62 Million exceeds net income of AU$1.55 Million, indicating high earnings quality where cash backs reported profits. Also explore total assets of Neuroscientific Biopharmaceuticals Ltd for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Neuroscientific Biopharmaceuticals Ltd Cash Flow Quality Index (2024–2024)
Historical Cash Flow Quality Index for Neuroscientific Biopharmaceuticals Ltd across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check NSB intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Neuroscientific Biopharmaceuticals Ltd (2024–2024)
Year-by-year earnings quality comparison for Neuroscientific Biopharmaceuticals Ltd. For live market cap and the full company financial profile, see NSB stock market capitalisation.
| Year | Quality Index | Operating CF (AUD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 0.14x | AU$44.25K | AU$324.21K | — |